Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBhatta, Archita-
dc.description.abstractThe TRIPS agreement has not been able to deliver the benefits promised to developing countries, which now need to plan ways to ensure that strict IP regimes do not become a tool for pharma companies in developed countries to milk the poor in the developing world.en_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceSR Vol.48(09) [September 2011]en_US
dc.titleTRIPS—Fifteen Years and Afteren_US
Appears in Collections:SR Vol.48(09) [September 2011]

Files in This Item:
File Description SizeFormat 
SR 48(9) 23-25.pdf537.81 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.